 I. To evaluate the safety and feasibility of adoptive transfer of autologous NY-ESO-1 T cell receptor TCR NY-ESO-1 reactive TCR retroviral vector transduced autologous PBLdominant-negative transforming growth factor-beta receptor II dnTGFbetaRII TGFbDNRII-transduced autologous tumor infiltrating lymphocytes TILs transgenic T cells. 